NeuroQuiet Reviews NeuroQuiet VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet Reviews In a market flooded with hearing supplements...
MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press...
Tests Were Created by Rutgers-Newark Researchers NEWARK, N.J., March 27, 2025 /PRNewswire/ -- Alzheimer's early detection tests using video games developed...
AD/PD™ 2025 to feature presentations on Linus Health's digital cognitive health assessments, plus attendees can learn more about company's recent...
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by the AISRS total score compared to placebo (p=0.039,...
Multiple datasets support continued development of ProMIS’ antibody therapeutics and vaccines that selectively target toxic misfolded proteins to treat neurodegenerative...
Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs Includes four planned new manufacturing...
Addition Bolsters Healthtech Pioneer's Innovation Trajectory; Accelerates Growth, Diversifies Offerings and Expands Global Reach SAN DIEGO, March 20, 2025 /PRNewswire/...
Neurotechnology Pioneer Utilizes Standardized Brain Data to Predict Human Behavior, Enhance Digital Systems across Consumer, Health, Defense, and Aerospace TEL...
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New York--(Newsfile Corp. - March 18,...
Southern California's Leading Medtech Octane's Premier Event Unites Global Stakeholders and Spotlights Innovations in Neuroscience and Technology for a Day...
SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel...
Acquisition further builds on Clario's neuroscience expertise and capabilities PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of...
NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it...
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) --...
Strategic investment in digital health solutions addressing critical challenges in primary care and chronic disease management Rome, Italy, 12 March...
PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment...
DAVIS, Calif., March 11, 2025 /PRNewswire/ -- openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv,...
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year...
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the...